Semaglutide starts reducing appetite within one to two weeks for most people. Meaningful weight loss becomes visible by weeks four to eight. Peak results develop over six to twelve months at the maintenance dose—subject to medical approval by a licensed provider at TelosRX.
Timelines vary by person. Your starting dose, titration schedule, and individual metabolic response all shape what you experience and when. Below, our clinical team answers the questions we hear most.
When Do You First Feel Semaglutide Working?
Most people notice reduced hunger within the first one to two weeks—sometimes after the first or second injection. The earliest signal is usually a shift in how food occupies mental space: smaller portions feel satisfying, and cravings quiet before the scale shows any change.
At the starting dose of 0.25 mg weekly, the appetite effect is intentionally mild. That dose is a tolerance-building step, not a therapeutic target. Don't judge the medication's effectiveness at week one or two.
When Does Weight Loss Actually Start?
Clinical data from the STEP 1 trial—which enrolled over 1,900 participants on 2.4 mg weekly semaglutide—showed measurable weight loss by week four in most participants. The loss curve steepened between weeks eight and twenty-four as doses escalated toward the therapeutic target.
Practically: expect the first one to three pounds in weeks two to four. Visible, meaningful loss typically follows by months two to three as you approach maintenance dosing.
How Does Dose Titration Work—and How Long Does It Take?
Semaglutide follows a standard escalation schedule designed to reduce GI side effects while the body adjusts:
| Weeks | Dose (once weekly) | Primary Goal |
|---|---|---|
| Weeks 1–4 | 0.25 mg | GI tolerance building |
| Weeks 5–8 | 0.5 mg | Moderate appetite effect |
| Weeks 9–12 | 1.0 mg | Meaningful suppression onset |
| Weeks 13–16 | 1.7 mg | Near-maximum effect |
| Week 17+ | 2.4 mg | Maintenance (therapeutic) dose |
Your provider may slow this schedule if nausea or GI side effects are significant. Rushing titration increases side effects without speeding up results. All dose changes require provider approval. See our semaglutide dosage guide for the full breakdown by week.
When Does Appetite Suppression Peak?
Full appetite suppression typically coincides with the maintenance dose—around weeks 17–20. The effect builds through three parallel mechanisms: slowed gastric emptying (food stays in the stomach longer, so you feel full faster), reduced ghrelin signaling (the hunger hormone that typically rises before meals), and altered reward pathways in the brain that reduce cravings for calorie-dense foods.
Some people notice a meaningful appetite shift at mid-range doses (1.0–1.7 mg), especially between weeks nine and twelve. If appetite hasn't changed at all by week six, mention it to your provider during your next asynchronous check-in.
What If Nothing Seems to Be Happening?
This is expected in weeks one through four. The 0.25 mg starting dose is a ramp-up step—most people don't feel a meaningful appetite effect until doses reach 0.5 mg or above, which happens at week five.
By weeks eight to ten with no appetite change—even subtle—report it to your provider. Non-responders exist, and tirzepatide (a dual GLP-1/GIP agonist) may be worth evaluating instead. That's a clinical decision requiring provider review and a provider-issued prescription. See our comparison: tirzepatide vs semaglutide—compounded GLP-1 options explained.
What Supports a Faster, Stronger Response?
You can't rush titration—that produces more side effects with no additional benefit. But these factors meaningfully support the timeline:
- Protein-forward eating — preserves lean mass during a caloric deficit and supports satiety between doses
- Resistance training — protects muscle tissue and maintains metabolic rate as weight comes off
- Consistent weekly dosing — semaglutide's half-life is approximately 160 hours; schedule consistency matters
- Quality sleep — sleep deprivation elevates ghrelin and directly opposes semaglutide's hunger-suppression effects
- Limiting alcohol — alcohol introduces blood sugar variability and can worsen GI side effects during dose escalation
Ready to explore your options? Start your private evaluation at TelosRX—licensed provider review, fully asynchronous, on your schedule.
How Does Tirzepatide's Timeline Compare?
Tirzepatide follows a similar escalation—2.5 mg to 15 mg over 20 weeks—but many providers report faster or stronger appetite suppression in some patients, possibly due to additive GIP receptor activation alongside GLP-1. In the SURMOUNT-1 trial, participants at the 15 mg dose achieved an average 22.5% body weight reduction at 72 weeks, compared to 2.5% in the placebo group.
Faster early feeling with tirzepatide is anecdotal across prescribers—individual response to either medication varies significantly. Both require titration. Your provider will evaluate which is appropriate for your situation, subject to medical approval by a licensed provider.
When Do Results Plateau, and What Then?
Most people hit a weight-loss plateau between months six and twelve at maintenance dose. This is physiological adaptation, not treatment failure. The body adjusts energy expenditure over time—a documented phenomenon in long-term GLP-1 trials.
At a plateau: evaluate protein intake, resistance training volume, and sleep quality. A provider can also evaluate dose or medication adjustment—all subject to provider approval. For a full guide, see GLP-1 weight loss plateau: why it happens and what to do.
Frequently Asked Questions
How long does semaglutide take to work for weight loss?
Most people see the first measurable weight loss within two to four weeks at escalating doses, with meaningful visible progress by weeks eight to twelve. Peak results typically develop after six to twelve months on the 2.4 mg maintenance dose, subject to medical approval by a licensed provider. Individual results vary.
When do you feel semaglutide's appetite effects?
Appetite changes—reduced hunger, smaller portions feeling satisfying—often begin within the first one to two weeks. The effect is mild at the 0.25 mg starting dose and builds as doses escalate over sixteen weeks. Most people report meaningful appetite suppression by weeks nine to twelve.
Does compounded semaglutide work the same as Ozempic or Wegovy?
Compounded semaglutide contains the same active molecule but is not FDA-approved. It is prepared under federal compounding regulations, not manufactured by Novo Nordisk. Efficacy depends on individual response, dose, and formulation. All use requires evaluation by a licensed provider; approval is not guaranteed.
What if semaglutide isn't working after a month?
At four weeks you are likely still at the 0.25 mg ramp-up dose—below therapeutic range. No effect at this stage is expected. If there is no appetite change by weeks eight to ten at escalating doses, report it to your provider. Dose adjustment or a different medication may be appropriate.
How long does semaglutide take to suppress appetite versus tirzepatide?
Both suppress appetite through GLP-1 receptor activation, but tirzepatide also activates GIP receptors. Some prescribers report faster appetite effects with tirzepatide in certain patients. Individual response varies significantly. Both require titration to therapeutic doses over 16–20 weeks, subject to provider review and a provider-issued prescription.
Is compounded semaglutide FDA-approved?
Compounded semaglutide is not FDA-approved. The branded versions Ozempic (for type 2 diabetes) and Wegovy (for chronic weight management) hold FDA approval. Compounded semaglutide is prepared under federal compounding regulations and dispensed only after evaluation by a licensed provider; approval is not guaranteed.
How long does semaglutide stay in your system after stopping?
Semaglutide has a half-life of approximately 160 hours (about one week). After stopping, it clears over four to five weeks. Appetite and weight often return after stopping. See how long semaglutide stays in your system for the full pharmacokinetic breakdown.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.